The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
Heart disease deaths related to obesity increased by 180% in the U.S. between 1999 and 2020, especially among middle-aged men, Black adults, residents of Midwestern states and non-metropolitan areas, ...
Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.
Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.
Heart disease, type 2 diabetes, high blood pressure and obesity were more common and linked to reduced access to healthy ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
"Obesity is a serious risk factor for ischemic heart disease, and this risk is going up at an alarming rate along with the increasing prevalence of obesity," lead researcher Dr. Aleenah Mohsin, a post ...
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...
New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...
Study participants who averaged between 2.5 and 5 hours of physical activity a week—which is the minimum amount recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback